Antidepressant treatment of CUMS mice revealed that changes in the levels of miR-34a-5p, miR-126, miR-200a-3p, and miR-144-3p influenced the BDNF–ERK/Akt signalling pathway and participated in the development of depression. The gene discussed is BDNF; the disease is depressive symptom measurement.